Common Contracts
2 similar Securities Purchase Agreement contracts by CASI Pharmaceuticals, Inc., Sparkle Byte LTD
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 25th, 2016 • Sparkle Byte LTD • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made as of September 20, 2015, between CASI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), He Xie Ai Qi Investment Management (Beijing) Co., Ltd. (和谐爱奇投资管理（北京）有限公司), a company formed under the laws of the People’s Republic of China (“HXAQ”) and any Person that delivers any portion of the Subscription Amount pursuant to Section 2.02(b) of this Agreement (such Persons, together with HXAQ, jointly and severally, and including their successors and assigns, the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2015 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made as of September 20, 2015, between CASI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), [________________], a company formed under the laws of [_________] (“[______]”) and any Person that delivers any portion of the Subscription Amount pursuant to Section 2.02(b) of this Agreement (such Persons, together with [______], jointly and severally, and including their successors and assigns, the “Purchaser”).
